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Abstract
Background: MR-Egger regression has recently been proposed as a method for
Mendelian randomization (MR) analyses incorporating summary data estimates of
causal effect from multiple individual variants, which is robust to invalid instruments. It
can be used to test for directional pleiotropy and provides an estimate of the causal effect
adjusted for its presence. MR-Egger regression provides a useful additional sensitivity
analysis to the standard inverse variance weighted (IVW) approach that assumes all vari-
ants are valid instruments. Both methods use weights that consider the single nucleotide
polymorphism (SNP)-exposure associations to be known, rather than estimated. We call
this theNO Measurement Error’ (NOME) assumption. Causal effect estimates from the
IVW approach exhibit weak instrument bias whenever the genetic variants utilized violate
the NOME assumption, which can be reliably measured using the F-statistic. The effect
of NOME violation on MR-Egger regression has yet to be studied.
Methods: An adaptation of the I2 statistic from the field of meta-analysis is proposed to
quantify the strength of NOME violation for MR-Egger. It lies between 0 and 1, and indi-
cates the expected relative bias (or dilution) of the MR-Egger causal estimate in the two-
sample MR context. We call it I2GX . The method of simulation extrapolation is also
explored to counteract the dilution. Their joint utility is evaluated using simulated data
and applied to a real MR example.
Results: In simulated two-sample MR analyses we show that, when a causal effect exists,
the MR-Egger estimate of causal effect is biased towards the null when NOME is violated,
and the stronger the violation (as indicated by lower values of I2GX ), the stronger the dilu-
tion. When additionally all genetic variants are valid instruments, the type I error rate of
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the MR-Egger test for pleiotropy is inflated and the causal effect underestimated.
Simulation extrapolation is shown to substantially mitigate these adverse effects. We
demonstrate our proposed approach for a two-sample summary data MR analysis to es-
timate the causal effect of low-density lipoprotein on heart disease risk. A high value of
I2GX close to 1 indicates that dilution does not materially affect the standard MR-Egger
analyses for these data.
Conclusions: Care must be taken to assess the NOME assumption via the I2GX statistic
before implementing standard MR-Egger regression in the two-sample summary data
context. If I2GX is sufficiently low (less than 90%), inferences from the method should be
interpreted with caution and adjustment methods considered.
Key words: Mendelian randomization, MR-Egger regression, measurement error, I2 statistic, simulation extrapolation
Introduction
Mendelian randomization (MR)1 has become an estab-
lished method for probing questions of causality in obser-
vational epidemiology. By making use of genetic variants
satisfying the instrumental variable (IV) assumptions, it is
possible to test whether an exposure causally influences a
health outcome by circumventing the problem of con-
founding that compromises standard associational meth-
ods. The explosion in publicly available summary data
estimates of genetic association from large international
genome-wide association (GWA) consortia2,3 has made
MR ever more popular for two reasons. First, summary
data estimates of causal effect from multiple genetic vari-
ants can be simply and transparently combined to yield
results that closely mirror what would be obtained with in-
dividual participant data.4,5 Second, a dramatic rise in the
number of variants available for the analysis has led to an
increased power for testing causal hypotheses.6 In this
paper we focus on the most common form of summary
data MR study, whereby genetic associations with the ex-
posure and outcome are gleaned from independent samples
to furnish atwo-sample’ analysis.4
The standard method for MR with summary data
[referred to as the standard inverse variance weighted
(IVW) approach5,7] makes the fundamental assumption
that each included variant is a valid IV. That is, it is (i)
associated with the exposure, (ii) not associated with any
confounders of the exposure and outcome, and (iii) is only
Key Messages
• MR-Egger regression provides a simple method for Mendelian randomization of summary data estimates that is ro-
bust to invalid instruments.
• MR-Egger regression is not designed to replace the standard approach as the primary analysis, but is an important
sensitivity analysis to probe whether the IV assumptions have been violated in a meaningful way.
• MR-Egger assumes, like the standard implementation of the IVW method, that the variance of SNP-exposure associ-
ation estimates is negligible (the NOME assumption).
• In the two-sample MR setting, if NOME is violated (as quantified by an I2GX much less than 1) but InSIDE is satisfied,
MR-Egger regression will tend to underestimate the causal effect and potentially inflate the type I error rate of the
MR-Egger test for pleiotropy.
• An I2GX value of 0.9 indicates a relative bias in the MR-Egger causal effect estimate of 10%. It provides an appropriate
measure of instrument strength in the two-sample context.
• Like all statistics, I2GX is an estimate: its variability will be affected by the strength of the instruments (as measured by
the F-statistic) and the total number of instruments.
• Simulation extrapolation can be used to correct MR-Egger regression parameters for NOME violation, and in doing
so reduce the type I error rate of the MR-Egger test for pleiotropy. Further research is required to find the optimal
method of bias correction.
• NOME violation does not affect the type I error rate of the MR-Egger causal effect estimate.
• Further research is required to assess the effect of NOME violation in the single-sample MR context.
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associated with the outcome through the exposure (see
Figure 6 available as Supplementary data at IJE online). If
(i–(iii) hold, then an inverse variance weighted average of
the individual causal effect estimates (e.g. as in a meta-
analysis) is both efficient and unbiased. Unfortunately,
assumptions (ii)–(iii) are unlikely to hold in an MR study,
particularly in the summary data setting when large num-
bers of variants are harvested from GWA studies and
included in the analysis. For example, as part of a repertoire
of MR analyses, Holmes et al.8 conduct an MR-analysis of
high density lipoprotein cholesterol on heart disease risk by
liberally including many genetic variants that were also
associated with other lipid fractions (e.g. triglycerides). This
could introducehorizontal pleiotropy’9 and lead to violation
of assumption (ii) or (iii) due to variants affecting the out-
come via a different biological pathway. This could in turn
lead to bias, type I and type II error inflation, if unaccounted
for. MR-Egger regression10 is a recently proposed method
to both detect and adjust for pleiotropy in an MR-analysis.
Like all IV methods, the IVW approach is known to be
vulnerable to weak instrument bias, which can be quanti-
fied for each genetic variant included in the analysis via its
F-statistic.11 However, the F-statistic is not a sufficient indi-
cator of instrument strength for MR-Egger. In this paper we
clarify that instrument strength has a very different meaning
for MR-Egger in the two-sample summary data context; it
is a collective property of all genetic variants included in the
analysis, and aweak set’ of instruments can be understood
as inducing regression dilution bias12,13 into its estimate
of causal effect. We formalize the cause of this dilution by
defining it as a violation of the NO Measurement Error’
(NOME) assumption. The I2 statistic14 is proposed to
quantify the strength of NOME violation for a set of instru-
ments used for MR-Egger regression, and the expected
magnitude of regression dilution that will occur. We also
describe how the established method of simulation extrapo-
lation (SIMEX)15,16 can be used for bias-adjusted inference.
In the Methods section, we review the IVW and MR-
Egger regression approaches to Mendelian randomization in
the two-sample summary data context. We then explain the
consequences of NOME violation for both methods for
several hypothetical but general scenarios. In the Results sec-
tion, we first show the impact of NOME violation on MR-
Egger causal estimates using simulated data and the perform-
ance of bias adjustment via SIMEX. We then demonstrate
our methods for a real two-sample summary data MR ana-
lysis on the effect of low-density lipoprotein and heart dis-
ease, using summary data from the Global Lipids Genetics
and CARDIoGRAM consortia.2,3 We conclude with a dis-
cussion of the issues raised and point to future research.
Technical details are kept to a minimum in the main
body of the paper; the interested reader is directed to the
Appendix (available as Supplementary data at IJE online)
for further clarification where appropriate.
Methods
Modelling assumptions
We assume that normally distributed summary data esti-
mates are available for the single nucleotide polymorphism
(SNP)-exposure associations (bc1,. . .,bcL) and SNP-outcome
associations (bC1,. . .,bCL) of L uncorrelated variants, and
have been obtained in independent samples of non-
overlapping participants for the purposes of a two-sample
MR study. We allow the precision of these estimates to dif-
fer across variants (for example due to allele frequency),
denoting the variance of the jth SNP-exposure association
and SNP-outcome association as r2Xj and r
2
Yj, respectively.
We assume throughout that each variant is truly associated
with the exposure [IV assumption (i) holds] so that the
underlying SNP-exposure association parameters c1; . . . ; cL
are all non-zero. Furthermore, we assume that the genetic
data have been coded so that SNP-exposure associations
are all positive. Our models for the jth SNP-exposure and
SNP-outcome associations are as follows:
bcj  Nðcj;r2XjÞ; bCj  Nðaj þ bcj; r2YjÞ: (1)
Here b represents the true causal effect that we wish to
estimate and aj allows for the possibility that genetic vari-
ant j could affect the outcome via a separate molecular
pathway from the exposure X. We refer to aj as the pleio-
tropic effect of variant j. A more detailed description of the
modelling assumptions is provided in the Appendix (avail-
able as Supplementary data at IJE online).
The ratio estimate for the causal effect derived from the
jth variant only, bbj, is equal to the SNP-outcome associ-
ation divided by the SNP-exposure association, bCj=bcj.17 If
variant j is a valid IV, then it is a consistent estimate for the
causal effect b. It is common practice to assume that the
variance of the SNP-exposure association is negligible.5–7
We call this the NO Measurement Error (NOME) assump-
tion. Taken at face value, NOME implies r2Xj ¼ 0 and
therefore the estimate bcj is identical to the true value cj for
all j. Under the NOME assumption, the variance of the jth
ratio estimate varðbbjÞ ¼ r2Yj=bc2j because bcj is treated as a
constant. This is equivalent to only the first term from a
full Taylor series expansion of varðbbjÞ.
The IVW approach
The inverse variance weighted (IVW) estimate, bbIVW , is a
weighted average of the ratio estimates bb1; . . . ; bbL. The
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IVW method (as originally proposed) assumes that all vari-
ants are valid IVs so that none of the genetic variants ex-
hibit pleiotropy and hence aj ¼ 0 for all j. It is common
practice to use inverse variance weights derived via
NOME5,7 so that it has the form:
bbIVW ¼
XL
j¼1
wjbbj
XL
j¼1
wj
; wj ¼ bc2j =r2Yj: (2)
The IVW estimate can be equivalently obtained as the
slope from a linear regression of the SNP-outcome associ-
ation estimates on the SNP-exposure association estimates
with the intercept term constrained to zero.
If the above assumptions are satisfied, bbIVW is an un-
biased estimate for b. However, NOME will never be per-
fectly satisfied in practice. In the presence of substantial
measurement error, the IVW estimate is known to suffer
from weak instrument bias,18 where instrument strength is
typically represented by the F-statistic. In the two-sample
summary data context and with uncorrelated genetic vari-
ants, the F-statistic for variant j can be approximated as Fj
¼ bc2j =r2Xj. We use this approximation for the remainder of
the paper. In the two-sample context considered here, the
effect of weak instrument bias is to attenuate the causal ef-
fect towards the null.4
MR-Egger regression
In contrast to the IVW method, MR-Egger regression10
does not assume that all of the SNP-outcome associations
are unaffected by pleiotropy, so the ajs are all allowed to
be non-zero. Put simply, it assumes that the magnitude of
the pleiotropic effects are independent of their strengths as
instruments. That is, the size of cj for variant j provides no
information as to the size of its corresponding aj. This is
referred to as the InSIDE (Instrument Strength Independent
of Direct Effect) assumption;10 see also the Appendix for a
more detailed discussion (available as Supplementary
data at IJE online). In common with the IVW method,
MR-Egger makes the NOME assumption. It performs a
regression of the SNP-outcome associations on the SNP-
exposure association of the form bCj ¼ b0E þ b1Ebcj.
Weighting the regression by the precision of bCj improves
efficiency and is recommended, but for simplicity of ex-
planation, we ignore this extra complication for now.
The intercept estimate bb0E can be interpreted as the
average pleiotropic effect across all variants and the slope
estimate bb1E provides an estimate for the true causal par-
ameter b. MR-Egger can only detect pleiotropy when it is
directional’ (i.e. it has a non-zero average value), since only
then will b0E be non-zero. It could be, for example, that all
variants exhibit pleiotropy, but on average it cancels out.
This is referred to asbalanced’ pleiotropy.10 When InSIDE
and NOME are perfectly satisfied, MR-Egger returns an
unbiased estimate for the causal effect b. However, when
InSIDE holds but NOME is violated, it will not be un-
biased; its expected value will equal the true value b multi-
plied by a scale factor between 0 and 1, as below:
Expected value of MR-Egger slope:
bb1E  bVarðcÞVarðbcÞ¼b
r2c
r2cþs2
: (3)
Here, r2c is the variance of the set of true SNP-exposure
associations c1; . . . ; cL and s
2 represents the additional
average’ variability among bc1; . . . ;bcL due to estimation (or
measurement) error. Only when s2 is zero will NOME be
satisfied. When the SNP-exposure estimates are more vari-
able than the underlying parameter values, so that s2 is
non-zero, the resulting NOME violation leads to the MR-
Egger estimate being attenuated towards zero, as per for-
mula (3). This attenuation can be understood as an arche-
typal case of regression dilution bias. A more detailed
explanation of formula (3) is given in the Appendix (avail-
able as Supplementary data at IJE online).
Assessing regression dilution with I2GX
The ratio varðcÞ=varðbcÞ in equation (3), and hence the mag-
nitude of the regression dilution, can be approximated
using the I2 statistic,14 a well-known tool for assessing be-
tween study heterogeneity in meta-analysis. First, define
Cochran’s Q statistic for the SNP-exposure associations to
be:
QGX ¼
XL
j¼1
ðbcj  bcÞ2
r2Xj
where bc is the mean of the SNP-exposure associations
(weighted by 1/r2Xj). Our corresponding I
2 statistic is then
defined to be I2GX ¼ ðQGX  ðL 1ÞÞ=QGX. Our approxi-
mation implies that, on average, bb1E is roughly equal to
bI2GX, as suggested by formula (3); see the Appendix for
further details and the slightly adapted formula for I2GX
under a weighted analysis, available as Supplementary
data at IJE online.
In order to clarify the definition of I2GX in the MR con-
text, we refer to Figure 1. The solid black dots show a scat-
ter plot of the SNP-outcome association estimates (the bCs)
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versus the true SNP-exposure associations (the cs). The
hollow black dots show the SNP-outcome association esti-
mates versus the SNP-exposure association estimates (the
bcs). In practice, we only observe the hollow black dots
(estimate versus estimate). The horizontal dashed lines cen-
tred at each solid black dot represents the region within
which we would expect to find the estimate bcj (hollow
black dot) with 95% probability, given that it is generated
from equation (1). These lines are proportional in length to
the standard error of each SNP-exposure association esti-
mate. Note that there is variation in the length of the
dashed lines, because each SNP-exposure standard error is
unique, depending on factors such as allele frequency. The
I2GX statistic represents the true variance of the SNP-
exposure associations, r2c (or spread of black dots) divided
by the variance of the SNP-exposure association estimates,
r2c þ s2 (or spread of hollow black dots).
The I2GX statistic therefore offers a convenient interpret-
ation. When the underlying SNP-exposure associations are
sufficiently heterogeneous, and the uncertainty in the SNP-
exposure association estimates is small in comparison with
this underlying variability, I2GX will be close to 1 and the at-
tenuation due to NOME violation will be negligible. If the
underlying associations are generally similar in magnitude,
or if their estimates are relatively imprecise (or both), then
I2GX could be much less than 1 and the attenuation will be se-
vere. An I2GX statistic of 0.9 provides the assurance that the
likely bias in bb1E due to measurement error is around 10%
of the true value of b. This is, equivalent to the assurance
provided by an F-statistic of 10 in traditional IV analyses.
The impact of regression dilution: further
examples
In order to gain further insight into the impact of regres-
sion dilution for MR-Egger, consider the scatter plots of
hypothetical summary data shown in Figure 2. Here we
have removed error bars indicating the uncertainty in the
SNP-exposure association estimates for clarity. In each
scatter plot, InSIDE is assumed to hold.
In Figure 2 (top left), we imagine that all variants are in-
valid instruments but the pleiotropy is balanced. That is,
a1; . . . ; aL are all non-zero but their average value is zero.
Furthermore, the causal effect b is positive. We also assume
that all the variants are strong instruments in the trad-
itional sense of having large F-statistics, but that NOME is
violated to the extent that I2GX ¼ 0.75. As before, each hol-
low black dot represents (bcj; bCj) [the SNP-exposure associ-
ation estimates versus the SNP-outcome association
estimates] whereas the solid black dots show the true cjs
plotted against the bCjs. Note again that the hollow black
dots are more variable than the solid black dots.
Since all instruments are strong and the pleiotropy is
balanced (b0E ¼ 0), the IVW estimate perfectly aligns with
the true slope, which is denoted by the solid black line.
However, because NOME is violated, we expect the MR-
Egger estimate to be diluted towards zero by a factor of
I2GX ¼ 3/4. This is shown by the solid blue line. Since the
slope and intercept parameter estimates from MR-Egger
are negatively correlated, this means that the intercept par-
ameter estimate is positively biased. In the Results section,
we show that this leads to an inflation in the type I error
rate of the MR-Egger test for directional pleiotropy.
Figure 2 (top right) shows the same scenario as Figure 2
(top left) except instead of balanced pleiotropy, there is
now negative directional pleiotropy. As before, the MR-
Egger slope parameter is diluted towards zero from b by a
factor of 3/4. In this case the intercept estimate is also atte-
nuated, meaning that the power of the MR-Egger test to de-
tect true directional pleiotropy is reduced. In this example
the IVW estimate (shown by the red line) is much closer to
the null, due to the pleiotropy acting in the opposite direc-
tion of the causal effect. Its bias is solely due to the incorrect
assumption that all variants are valid IVs, and not because
of regression dilution. Figure 2 (bottom left) shows the case
where there is positive directional pleiotropy and a positive
causal effect. In this example the IVW estimate is further
from the null, since the pleiotropy acts in the same direction
as the causal effect. The MR-Egger slope parameter is
diluted towards zero as before but the intercept estimate is
increased. However, since it is truly non-zero, this does not
lead to type I error inflation. Figure 2 (bottom right) shows
the case where there is positive directional pleiotropy, but
the causal effect is zero. In this case, violation of the
NOME assumption has no effect; if the causal effect is truly
zero then it cannot be attenuated any further. As in Figure
2 (bottom left), the IVW method mistakenly attributes the
positive pleiotropy to a causal effect.
Figure 1. Illustrative diagram showing the SNP-exposure associations (es-
timates ¼ hollow black dots, true values ¼ solid black dots) plotted against
the SNP-outcome association estimates for a fictional MR analysis.
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Bias adjustment via simulation extrapolation
An intuitive but crude bias-corrected estimate for the causal
effect would be bb1E=I2GX. In a preliminary investigation,
however, this approach did not work well. Even when the
true value of I2GX is large, its estimate is a random quantity
and can sometimes be close or equal to zero (as we will sub-
sequently illustrate and explain in Figure 3). Therefore, sim-
ply dividing the original MR-Egger estimate by I2GX can
yield unstable results. We found that the well-established
technique of simulation extrapolation (SIMEX)15 to be
more reliable. Under SIMEX, new data sets are created by
simulating SNP-exposure association estimates under
increasing violations of the NOME assumption. That is, for
each new data set, a new SNP-exposure estimate for variant
j is generated with a mean value equal to the observed esti-
mate ðbcjÞ, but with a variance that is (1þk) times as large as
r2Xj (where k is a non-negative number). The simulated data
are combined with the observed SNP-outcome estimates to
yield a new value for bb1E. This is repeated many times for
the same value of k to get an average value for bb1E, and the
whole process is repeated for a range of ks. The average
value of bb1E tends to get smaller as the magnitude of k in-
creases, since the regression dilution effect will be stronger.
A statistical model is then fitted to the set of average values
obtained across the ks, by treating them as data points. The
fitted model then enables the user to extrapolate back and
estimate the value of bb1E that would have been obtained if
NOME had been satisfied. This can be viewed conceptually
as setting k to -1 to perfectly remove the measurement
error: see Figure 5 for an illustration of the method in prac-
tice and the Appendix for further technical details (avail-
able as Supplementary data at IJE online). R and Stata
packages exist to implement SIMEX16,19, providing point
estimates as well as accompanying standard errors to en-
able full inference after bias adjustment.
Results
Simulations
In this section we demonstrate the impact of NOME viola-
tion (as measured by I2GX) on the performance of MR-
Egger regression and the IVW approach, and show the
utility of bias adjustment for MR-Egger regression via
SIMEX. Data sets of 25 SNP-exposure and SNP-outcome
associations were generated to furnish two-sample sum-
mary data MR analyses in the following manner.
SNP-exposure associations for a given F and I2GX
SNP-exposure standard errors rX1,. . .,rX25 and SNP-
exposure parameters c1; . . . ; c25 were drawn from Uniform
distributions and then used to generate SNP-exposure esti-
mates bc1; . . . ;bc25 from model (1). The lower and upper
bounds of these distributions were chosen in order to fix
Figure 2. Illustrative diagram showing the SNP-outcome association estimates plotted against both the SNP-exposure association estimates (hollow
black dots) and their true values (solid black dots). Top left: positive causal effect, balanced pleiotropy. Top right: positive causal effect, negative direc-
tional pleiotropy. Bottom left: positive causal effect, positive directional pleiotropy. Bottom right: no causal effect, positive directional pleiotropy.
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the true mean F-statistic (F) and I2GX to the specific values
desired. Initially, we fix F to be close to that of the lipids
data analysed in the following section (F ¼ 125) and then
consider four values of I2GX: 95%, 90%, 85% and 75%.
Both Table 4 and Figure 7 (left) in the Appendix (available
as Supplementary data at IJE online) show, for each value
of I2GX, the precise sampling distributions for r
2
X1,. . .,r
2
X25,
c1; . . . ; c25 and the resulting distribution of F-statistics
(with mean value 125). By letting r2X1,. . .,r
2
X25 take a range
of values, we can account for heterogeneity in the preci-
sions of SNP-exposure estimates present in real data due to
differing allele frequency.
SNP-outcome associations for a given pattern of pleiotropy
SNP-outcome standard errors were generated by setting
rYj equal to 2  rXj in order to reflect a common allele fre-
quency for a given variant j but different sample sizes in
the underlying SNP-exposure and SNP-outcome cohorts.
Pleiotropy parameters a1; . . . ; a25 were randomly generated
from a Uniform distribution under five distinct scenarios.
For a fixed causal effect, b, a1; . . . ; a25 and rY1; . . . ;rY25
were then used to generate SNP-outcome association esti-
mates bC1; . . . ; bC25 from model (1). The five simulation
scenarios explored were:
• Scenario 1: balanced pleiotropy [aj  Uniform(-0.2,0.2)]
and a positive causal effect: consistent with b ¼ b1E ¼ 1;
b0E ¼ 0;
• Scenario 2: negative directional pleiotropy [aj 
Uniform(-0.2,0)] and a positive causal effect: consistent
with b ¼ b1E ¼ 1; b0E ¼ 0:1;
• Scenario 3: positive directional pleiotropy [aj 
Uniform(0,0.2)] and a positive causal effect: consistent
with b ¼ b1E ¼ 1; b0E ¼ 0:1;
• Scenario 4: positive directional pleiotropy [aj 
Uniform(0,0.2)] and a zero causal effect: consistent with
b ¼ b1E ¼ 0;b0E ¼ 0:1;
• Scenario 5: no pleiotropy [all aj ¼ 0] and a zero causal ef-
fect: consistent with b ¼ b1E ¼ 0; b0E ¼ 0:
Note that in each scenario, the MR-Egger intercept par-
ameter b0E is equal to the arithmetic mean of the plei-
otropy parameter distribution. Scenarios 1, 2, 3 and 4
mirror the situations highlighted in Figure 2 (top-left, top-
right, bottom-left and bottom-right, respectively). The add-
itional scenario (scenario 5) is strictly the only one where
the assumptions underlying the IVW approach (as origin-
ally proposed) are satisfied.
An important facet of our simulations is that, for each
summary data set, SNP-exposure and pleiotropy param-
eters (the cs and as) are generated from independent distri-
butions, as in reference (10). Following this procedure
enables us to see how MR-Egger regression would work on
average across different MR data sets of the same size, as
opposed to a single data set with fixed parameter values.
This means we avoid having to pick specific values for the
cs and as, which could be seen as arbitrary. It also guaran-
tees that, across the simulations, the average correlation be-
tween instrument strength and pleiotropy parameters will
be zero (so that InSIDE is satisfiedon average’). However,
for any single data set, this correlation will be non-zero and
InSIDE will be strictly violated. We therefore refer to this
data-generating procedure as satisfying the weak’ InSIDE
assumption, a concept which is further clarified in the
Appendix, available as Supplementary data at IJE online.
Exploring all five scenarios under the four values of I2GX
gave 20 simulation settings in total. For the IVW approach,
we report the average causal effect estimate bbIVW and the
probability of rejecting the causal null hypothesis b ¼ 0.
For MR-Egger regression (with and without adjustment
via SIMEX) we report: the average estimate for the inter-
cept parameter bb0E and the probability of rejecting the null
hypothesis of no directional pleiotropy (b0E ¼ 0); and the
average estimate of the slope parameter bb1E and the
Figure 3. Left: distribution of I2GX estimates under scenario 1 for
F ¼ 20 and I2GX ¼ 0.60 when L ¼ 25 (blue), 50 (red) and 100 (black). Right: distribution
of I2GX estimates under scenario 1 for
F ¼ 125 and I2GX ¼ 0.95 when L ¼ 25 (blue), 50 (red) and 100 (black).
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probability of rejecting the causal null (b ¼ 0). All methods
were implemented as described in the Results section, using
t-tests for hypothesis testing at the 5% significance level.
The results, which are the average of 5000 simulations, are
shown in Table 1. We label the rejection probabilities as P:
when the null hypothesis is true, P equals the type I error
rate, and when the null hypothesis is false, P equals the
power. The first two columns of Table 1 show the true
value of I2GX and its average estimated value (they are close
but not exactly equal). The most striking single observa-
tion is that, across all simulation settings, the average un-
adjusted MR-Egger estimate of causal effect, bb1E, is
approximately equal to b times the average I2GX estimate,
in line with our theoretical prediction.
IVW results
Columns 3–4 of Table 1 show the performance of the IVW
method. Since the 25 instruments are very strong, as meas-
ured by F, the IVW method has an almost 100% rejection
rate of the causal null for scenarios 1–4 (which all contain
pleiotropy). However, this is its type I error rate for scen-
ario 4, since the causal null is true. The type I error rate of
the IVW estimate is preserved at the 5% level under scen-
ario 5, when no pleiotropy or causal effect exists. Across all
scenarios, the average value of bbIVW is very insensitive to
changes in I2GX. Under scenarios 1 and 5, it is approximately
unbiased and out-performs MR-Egger. Under scenarios
2–4, it is biased by a consistent amount due to the presence
of directional pleiotropy and is inferior to MR-Egger.
MR-Egger results
Columns 5–8 of Table 1 show the performance of the
standard MR-Egger method, and columns 9–12 show the
performance of MR-Egger with SIMEX adjustment. Under
scenario 1, there is balanced pleiotropy and a positive
causal effect (b0E ¼ 0, b ¼ 1). The results show that
increasing NOME violation (decreasing I2GX) leads to type
I error inflation of the MR-Egger test for pleiotropy above
the 5% level, due to over-estimation of b0E. When I
2
GX ¼
75%, the type I error rate is over 10%. Over-estimation of
Table 1. Results for simulation scenarios 1–5, F ¼ 125. P equals power for bb1E and bb IVW in scenarios 1, 2 and 3 and type I error
in scenarios 4 and 5. P equals power for bb0E in scenarios 2, 3 and 4 and type I error in scenarios 1 and 5
MR-Egger regression
I2GX IVW Standard approach SIMEX adjusted
True Est bbIVW (P) bb0E(P) bb1E(P) bb0E(P) bb1E(P)
Scenario 1: Balanced pleiotropy, b ¼ b1E ¼ 1, b0E ¼ 0
0.95 0.95 0.99 (1.00) 0.02 (0.06) 0.95 (1.00) 0.00 (0.05) 1.00 (1.00)
0.90 0.90 0.99 (1.00) 0.04 (0.07) 0.89 (0.94) 0.00 (0.05) 0.99 (0.94)
0.85 0.84 0.99 (1.00) 0.07 (0.08) 0.84 (0.73) 0.01 (0.06) 0.98 (0.73)
0.75 0.73 0.99 (1.00) 0.11 (0.10) 0.73 (0.41) 0.02 (0.06) 0.95 (0.44)
Scenario 2: Negative directional pleiotropy, b ¼ b1E ¼ 1, b0E ¼ -0.1
0.95 0.95 0.78 (1.00) 0.08 (0.28) 0.95 (1.00) 0.10 (0.38) 1.00 (1.00)
0.90 0.90 0.76 (1.00) 0.06 (0.12) 0.89 (1.00) 0.10 (0.20) 0.99 (1.00)
0.85 0.84 0.75 (1.00) 0.03 (0.07) 0.84 (0.94) 0.09 (0.14) 0.98 (0.94)
0.75 0.73 0.75 (1.00) 0.01 (0.05) 0.73 (0.69) 0.08 (0.09) 0.94 (0.71)
Scenario 3: Positive directional pleiotropy, b ¼ b1E ¼ 1, b0E ¼ 0.1
0.95 0.95 1.20 (1.00) 0.12 (0.56) 0.95 (1.00) 0.10 (0.39) 1.00 (1.00)
0.9 0.90 1.22 (1.00) 0.14 (0.46) 0.90 (1.00) 0.10 (0.24) 1.00 (1.00)
0.85 0.84 1.23 (1.00) 0.16 (0.41) 0.84 (0.94) 0.10 (0.19) 0.99 (0.94)
0.75 0.73 1.23 (1.00) 0.21 (0.41) 0.73 (0.68) 0.12 (0.16) 0.94 (0.69)
Scenario 4: Positive directional pleiotropy, b ¼ b1E ¼ 0, b0E ¼ 0.1
0.95 0.95 0.21 (0.98) 0.10 (0.46) 0.00 (0.05) 0.10 (0.43) 0.00 (0.05)
0.90 0.90 0.23 (0.99) 0.10 (0.29) 0.00 (0.05) 0.10 (0.25) 0.00 (0.05)
0.85 0.84 0.24 (1.00) 0.10 (0.20) 0.00 (0.05) 0.10 (0.17) 0.00 (0.06)
0.75 0.73 0.24 (1.00) 0.10 (0.15) 0.01 (0.05) 0.10 (0.12) 0.01 (0.06)
Scenario 5: No pleiotropy, b ¼ b1E ¼ 0, b0E ¼ 0
0.95 0.95 0.00 (0.06) 0.00 (0.04) 0.00 (0.05) 0.00 (0.05) 0.00 (0.05)
0.90 0.90 0.00 (0.05) 0.00 (0.05) 0.00 (0.05) 0.00 (0.05) 0.00 (0.05)
0.85 0.84 0.00 (0.06) 0.00 (0.05) 0.00 (0.05) 0.00 (0.05) 0.00 (0.05)
0.75 0.73 0.00 (0.05) 0.00 (0.05) 0.00 (0.05) 0.00 (0.06) 0.00 (0.06)
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b0E coincides with under-estimation of the causal effect for
MR-Egger and a reduction in the power to reject the causal
null. SIMEX is able to mitigate the bias in bb1E caused by
measurement error, reduce the type I error rate of the MR-
Egger test for pleiotropy and leave the power to detect a
causal effect unchanged.
Under scenario 2, there is negative directional plei-
otropy and a positive causal effect (b0E ¼ -0.1, b ¼ 1).
Increasing NOME violation (decreasing I2GX) has the effect
of reducing the power to detect directional pleiotropy and
the power to detect a causal effect for MR-Egger. By ad-
justing for bias in bb1E, SIMEX is able to marginally in-
crease the power to detect directional pleiotropy and leave
the power to detect a causal effect unchanged. Under scen-
ario 3, there is positive directional pleiotropy and a posi-
tive causal effect (b0E ¼ 0.1, b ¼ 1). The results are
broadly similar to scenario 1. However, since there is true
directional pleiotropy, the power to detect it increases with
increasing NOME violation for MR-Egger. Applying
SIMEX to successfully correct for bias in bb0E and bb1E then
actually reduces the power to detect pleiotropy.
Under scenario 4, there is positive directional pleiotropy
and a zero causal effect (b0E ¼ 0.1, b ¼ 0). The results con-
firm that when the causal null hypothesis is true, the MR-
Egger estimate bb1E is unbiased and consequently the type I
error rate of the MR-Egger causal effect estimate is main-
tained at its nominal level. This is true regardless of the
strength of NOME violation. Applying SIMEX in this case
has no effect on inference for the causal effect, but slightly
reduces the power to detect directional pleiotropy. Under
scenario 5 there is no pleiotropy, and a zero causal effect
(b0E ¼ 0, b ¼ 0). In this case, the IVW method and MR-
Egger (with and without SIMEX) all unbiasedly estimate
their model parameters and their tests maintain the correct
type I error rate.
Further results for F 5 20
Table 2 shows the results for a near identical simulation
study, except that the mean instrument strength F is fixed
at 20 and the true I2GX values are varied between 60% and
40%. The strength and effect of the NOME violation are
now much more severe.
Both Table 4 and Figure 7 (right) in the Appendix
(available as Supplementary data at IJE online) show, for
each value of I2GX, the precise sampling distributions for
rX1,. . .,rX25, c1; . . . ; c25 and the resulting distribution of F-
statistics (with mean value 20). Higher values of I2GX are
not mathematically possible when F is low, without letting
the strength of individual genetic variants get unnaturally
Table 2. Results for simulation scenarios 1–5. F ¼ 20. P equals power for bb1E and bbIVW in scenarios 1, 2 and 3 and type I error in
scenarios 4 and 5. P equals power for bb0E in scenarios 2, 3 and 4 and type I error in scenarios 1 and 5
MR-Egger regression
I2GX IVW Standard approach SIMEX adjusted
True Est bbIVW (P) bb0E(P) bb1E(P) bb0E(P) bb1E(P)
Scenario 1: Balanced pleiotropy, b ¼ b1E ¼ 1, b0E ¼ 0
0.60 0.56 0.95 (1.00) 0.18 (0.22) 0.56 (0.38) 0.08 (0.10) 0.81 (0.41)
0.50 0.47 0.94 (1.00) 0.21 (0.28) 0.47 (0.24) 0.11 (0.12) 0.71 (0.29)
0.40 0.35 0.94 (1.00) 0.26 (0.33) 0.35 (0.14) 0.17 (0.15) 0.57 (0.19)
Scenario 2: Negative directional pleiotropy, b ¼ b1E ¼ 1, b0E ¼ -0.1
0.60 0.56 0.73 (1.00) 0.08 (0.09) 0.56 (0.42) 0.03 (0.08) 0.81 (0.46)
0.50 0.47 0.72 (1.00) 0.11 (0.13) 0.47 (0.29) 0.01 (0.09) 0.72 (0.34)
0.40 0.36 0.71 (1.00) 0.16 (0.19) 0.35 (0.16) 0.07 (0.10) 0.57 (0.21)
Scenario 3: Positive directional pleiotropy, b ¼ b1E ¼ 1, b0E ¼ 0.1
0.60 0.56 1.17 (1.00) 0.28 (0.54) 0.56 (0.42) 0.18 (0.22) 0.81 (0.46)
0.50 0.47 1.17 (1.00) 0.31 (0.56) 0.47 (0.28) 0.21 (0.24) 0.71 (0.33)
0.40 0.35 1.17 (1.00) 0.35 (0.62) 0.37 (0.18) 0.26 (0.28) 0.59 (0.24)
Scenario 4: Positive directional pleiotropy, b ¼ b1E ¼ 0, b0E ¼ 0.1
0.60 0.56 0.22 (0.54) 0.10 (0.12) 0.00 (0.05) 0.10 (0.11) 0.00 (0.07)
0.50 0.46 0.23 (0.56) 0.10 (0.12) 0.01 (0.06) 0.10 (0.11) 0.01 (0.08)
0.40 0.35 0.23 (0.57) 0.10 (0.11) 0.00 (0.06) 0.10 (0.12) 0.01 (0.09)
Scenario 5: No pleiotropy, b ¼ b1E ¼ 0, b0E ¼ 0
0.60 0.56 0.00 (0.05) 0.00 (0.05) 0.00 (0.06) 0.00 (0.07) 0.00 (0.07)
0.50 0.46 0.00 (0.05) 0.00 (0.06) 0.00 (0.06) 0.00 (0.09) 0.00 (0.08)
0.40 0.36 0.00 (0.06) 0.00 (0.05) 0.00 (0.06) 0.00 (0.09) 0.00 (0.09)
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close to zero [in the sense that they would not be chosen as
instruments in the first place due to violation of IV assump-
tion (i)].
Across all simulations settings, the average estimated
value of I2GX (column 2) multiplied by the causal effect b
still perfectly predicts the average MR-Egger causal esti-
mate bb1E (column 8). However, SIMEX adjustment is less
effective in correcting the MR-Egger parameters for bias
when a causal effect exists (scenarios 1–3). In scenarios 4
and 5, where the causal null is true, unadjusted MR-Egger
estimates are well behaved with the correct type I error
rate, whereas SIMEX adjustment slightly increases the type
I error rate above the nominal level. Thus, under the causal
null and when F and I2GX are low, bias adjustment can ac-
tually be worse than no adjustment at all.
Estimation of I2GX as a function of
F and L
The I2GX statistic is estimated from the data, and is there-
fore subject to error. Its variability will be affected by the
strength of the instruments (as measured by F) and the
total number of instruments, L. Figure 3 (left) shows the
distribution of I2GX estimates under scenario 1 when
F ¼
20, the true value of I2GX ¼ 0.6 and when L is 25, 50 and
100. Figure 3 (right) shows the distribution of I2GX esti-
mates under scenario 1 when F ¼ 125, the true value of
I2GX ¼ 0.95 and when L is 25, 50 and 100. In both plots it
is apparent that, as L increases, the variability in I2GX esti-
mates decreases and its distribution becomes less skewed.
Crucially, for the F ¼ 20 case, increasing L removes the
possibility of estimating I2GX to be zero. This clarifies why
the crude adjustment for NOME violation (dividing bb1E by
the estimated I2GX) can fail when
F and L are low. On the
contrary, we see in Figure 3 (right) that, when F, L and
I2GX are high, the variability in estimated I
2
GX is sufficiently
small for crude bias adjustment to work well.
Assessing the causal effect of LDL-c on CAD
There is a long and extensive literature on the association
between various lipid fractions and coronary artery disease
(CAD), but still far from universal agreement as to whether
all these associations have a causal basis. We focus on the
possible role of the least controversial lipid, low-density
lipoprotein cholesterol (LDL-c), in modifying CAD risk.
Using summary data from the Global Lipids Genetics
Consortium (GLGC)3 to provide SNP-LDL-c association
estimates, and summary data from CARDIoGRAM2 to
provide SNP-CAD association estimates, we perform a
two-sample MR analysis to illustrate the utility of MR-
Egger regression and the I2GX statistic.
Since LDL-c levels are closely related and highly corre-
lated with other lipid fractions, we selected the 57 variants
that were more strongly associated with LDL-c than with
triglycerides or high density lipoprotein. This strategy (al-
though not foolproof) aimed to reduce the possibility that,
if pleiotropy existed among the variants, it is operating via
a confounder of LDL-c and CAD. This would violate IV
assumption (ii) and lead to violation of InSIDE. This would
in turn bias the results from MR-Egger regression (regard-
less of the value of I2GX) as explored in reference (10). The
minimum P-value for the strength of association across all
variants was 8.3107. The mean F-statistic across all
included variants was 132, the weakest being 30 and the
strongest being 1325.
Figure 4 (left) shows a scatter plot of the SNP-outcome
log-odds ratio associations (bCj) versus the SNP-exposure
associations (bcj) across all 57 included variants. The data
are scaled so that the causal effect estimates represent log-
odds ratios of CAD for a standard deviation increase in
LDL-c. Figure 4 (right) shows a funnel plot20 of the causal
effect estimates bbj ¼ bCj=bcj on the x-axis versus their inverse
standard error (a measure of their strength as instruments)
on the y-axis. The funnel representation is a convenient
Figure 4. Left: scatter plot of the summary data estimates, with IVW and MR-Egger slope estimates shown. Right: funnel plot of the causal effect esti-
mates, with overall estimates under the IVW and MR-Egger approaches (with and without SIMEX correction).
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tool for assessing the presence of directional pleiotropy.
This would induce a correlation between effect size and
instrument strength, leading to asymmetry in the plot.10
The IVW method estimates a strong positive causal effect
of 0.45. However, there is reason to believe this analysis
to be misleading, given that some asymmetry exists.
Applying MR-Egger regression using code provided in
online supplementary material accompanying reference
(10) (and weighting by the inverse standard error of the
SNP-outcome association to improve efficiency), negative
directional pleiotropy is detected, although the evidence is
not particularly strong. Consequently, the point estimate
for b1E is adjusted upward to 0.63.
We now assess the potential for regression dilution bias to
attenuate the MR-Egger estimate for the causal effect. Under
the weighted analysis considered here, I2GX is calculated from
QGX using the weighted SNP-exposure associations and cor-
responding standard errors (bcj=rYj, rXj=rYj), whereas the un-
weighted analysis uses (bcj, rXj); see the Appendix for further
details, available as Supplementary data at IJE online. For
these data, I2GX equals 0.971 for the standard weighted ana-
lysis and 0.974 for an unweighted analysis. A crude bias ad-
justment would therefore be 0.63/I2GX ¼ 0.65. We used the
simex() package in R19 to implement the SIMEX method,
choosing the quadratic model for the extrapolation (see
Appendix). The SIMEX estimate was in very close to agree-
ment with the crude bias-adjusted estimate of 0.65, as illus-
trated in Figure 5. Indeed, this is exactly what our
simulations predicted given the observed values of I2GX,
F and
L (see Figure 3). Full results for all three methods are shown
in Table 3. As in the supplementary material accompanying
reference (10), causal effect estimates (Est), standard errors
(SE), P-values and t-test values are calculated for each
method under a multiplicative random effects model that ac-
counts for over-dispersion (in this case due to pleiotropy).
In conclusion, although borderline evidence of plei-
otropy exists across the included variants, there is still
strong evidence that LDL-c is causally related to CAD risk.
MR-Egger regression revises the causal effect of LDL-c up-
wards, because the apparent causal effect is masked by
pleiotropy acting in the opposing direction. Applying the
SIMEX algorithm revises the estimate slightly further still,
although a corresponding small increase in the standard
errors leaves inference largely unchanged. We can at least
confidently state that NOME violation is not a problem
for these data.
It is of course perfectly possible that our strategy for
including (and excluding) variants in the analysis could in
fact be unduly influencing the results by inducing collider
bias. We do not therefore claim that this approach is super-
ior to the more liberal inclusion policy adopted by Holmes
et al.8 in their main analysis, or that any single approach
should be relied upon. Holmes et al. sensibly consider a
range of analyses to address the problem of pleiotropy, for
example by constructing bothrestricted’ andunrestricted’
gene scores. A spectrum of possible rules for including vari-
ants in an MR study are also discussed and implemented
for very similar data by Bowden et al.21 Although we en-
courage such sensitivity analyses, they are beyond the
scope of this paper.
Discussion
The standard IVW method of Mendelian randomization
with summary data makes the strong assumption that all
variants are valid instruments, due to a complete absence
of pleiotropy. However, if pleiotropy is present but bal-
anced (as in Scenario 1 of the simulation study), it can still
return unbiased estimates of causal effect and is consider-
ably more powerful than MR-Egger regression.
Unfortunately, the IVW method can give biased results
under cases of directional pleiotropy and incorrectly infer
causality (as in Scenario 4 of the simulations). MR-Egger
Figure 5. Simulation extrapolation applied to the MR-Egger regression
analysis of the lipids data. The adjusted estimate is that predicted by
the model at the value k ¼ -1.
Table 3. IVW and MR-Egger regression analysis (with and
without SIMEX adjustment) of the lipids data
Model
Parameter Est SE t-value p-value
IVW approach
bIVW 0.45 0.053 8.51 1.13e-11
MR-Egger regression
b0E 0.0102 0.0046 2.23 0.0298
b1E 0.632 0.0975 6.481 2.66e-08
MR-Egger regressionþSIMEX
b0E 0.0109 0.0047 2.33 0.0236
b1E 0.6500 0.10000 6.47 2.76e-08
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regression, by contrast, is more robust to directional plei-
otropy. It is not designed to replace the standard approach
in the primary analysis, but is an important sensitivity ana-
lysis tool to probe whether the IV assumptions have been
violated in a meaningful way.
Both the IVW and MR-Egger regression methods are
traditionally implemented by assuming the SNP-exposure
association is measured without error (the NOME assump-
tion). Unfortunately, the price paid for MR-Egger’s
increased robustness to pleiotropy is a corresponding de-
crease in its robustness to violations of NOME, which
manifests itself as regression dilution bias. Our work sug-
gests that, in two-sample MR studies, the I2GX statistic is a
much more relevant summary measure for MR-Egger
regression than the traditional F-statistic. Whereas the F-
statistic is defined for each genetic variant and provides an
independent assessment of its strength within an IVW ana-
lysis, I2GX tells us that instrument strength is a singular, col-
lective property of all variants within an MR-Egger
analysis. Although better measures of instrument strength
may still be developed for MR-Egger regression, the simpli-
city of I2GX in calculation and interpretation make it an at-
tractive option.
Limitations and further work
Our focus in this paper was to explain the effect of viola-
tions to the NOME assumption on the performance of
MR-Egger regression in the two-sample summary data
context, and its connection to I2GX. Further work is
required to understand the effect of NOME violation on
MR-Egger regression when using a single-study popula-
tion. The picture is likely to be more complex in this set-
ting, since weak variants will induce bias towards the
observational estimate, with the magnitude of the bias
depending on the (unknown) strength of confounding. It
may therefore be hard or impossible to find a statistic (like
I2GX) to quantify this bias.
In order to make things as clear as possible, we purpose-
fully simplified our two-sample MR data-generating model
in several ways. First, data were simulated under the
InSIDE assumption, so that we could be sure MR-Egger
would return unbiased estimates when NOME is satisfied.
If InSIDE is violated, for example due to pleiotropic effects
acting via a confounder as explored in reference (10), an
MR-Egger analysis would yield biased estimates even if
I2GX were equal to 1. In practice, for I
2
GX values less than 1,
its bias will likely be due to violations of InSIDE and
NOME. Second, we generated summary SNP-exposure
and SNP-outcome association estimates from independent
normal distributions with known variance, rather than
simulating the individual participant data directly, to
furnishidealised’ two-sample MR analyses. This removed
the two further issues of non-collapsibility and ascertain-
ment bias which are often encountered in practice when
the outcome is binary and case-control data are used to es-
timate log-odds ratios for the SNP-outcome associations.22
Extending methods such as MR-Egger regression to prop-
erly account for these issues is an important line of future
research.
In this paper we showcased just one method of bias ad-
justment in the presence of measurement error, namely the
SIMEX approach.15,16 We chose this because of its wide-
spread use across statistics, its intuitive nature and its ap-
plicability to a wide range of statistical models. Software is
also readily available to implement the approach in prac-
tice with very little computational burden. Of course, users
may simply wish to implement a naive correction by divid-
ing the observed MR-Egger causal estimate by I2GX.
Although this will often be sufficient with a large number
of strong instruments (as seen in the simulations and the
lipids analysis) we do not think it is a reliable method in
general. Furthermore, an estimate for the variance of the
naive correction would also be needed to enable full statis-
tical inference.
It is possible that alternative methods of bias adjustment
could work better in the MR context, such as the plethora
of approaches discussed in references13,23,24. For example,
Sharp25 recommends a natural Bayesian formulation of the
problem, where the bias issue can be circumvented by
focusing directly on the parameters which subsequently
generate the observed data affected by measurement error.
However, it is worth noting that, by virtue of being shrunk
towards zero, uncorrected estimates tend to have a smaller
variance. Viewed through this lens, bias adjustment can
then be seen as applying the appropriate correction factor
to reverse’ the shrinkage, but at the cost of a reduced
precision.
Model selection techniques have recently been proposed
for MR analysis with the purpose of detecting and adjust-
ing for invalid instruments, using methods that assume at
least half of the genetic variants are valid instru-
ments.21,26,27 MR-Egger regression can work even if all
variants are invalid (under InSIDE), but our work has
shown that its performance will be best when the I2GX stat-
istic is large. An obvious follow-on question, therefore, is
whether it is sensible to adopt a strategy to increase the
value of I2GX for the analysis at hand. For example, it
would be possible to combine variants together into a
number of separate allele scores and to perform MR-Egger
regression on them instead. The SNP-exposure estimates
obtained from the individual allele scores would be smaller
in number but more precise than those based on the indi-
vidual variants, and could therefore give rise to a higher
12 International Journal of Epidemiology, 2016, Vol. 0, No. 0
 at Im
perial College London on Septem
ber 16, 2016
http://ije.oxfordjournals.org/
D
ow
nloaded from
 
I2GX, as desired. These ideas naturally complement allele
score approaches that have been shown to successfully
mitigate weak instrument bias when performing standard
two-stage least squares or IVW analyses.18,28
In conclusion, assessing the strength of NOME violation
is an important prerequisite to performing causal inference
with summary data, especially with MR-Egger regression. It
is unfortunate that this fact was not clarified in the original
publication by Bowden et al.,10 and we suspect the data ex-
amples contained in this paper would benefit from a more
considered analysis in light of our increased understanding.
It is comforting to note that standard MR-Egger regression
remains a reliable method for testing the causal null hypoth-
esis, even when NOME is violated. We recommend evaluat-
ing the I2GX statistic alongside an MR-Egger analysis. If it is
sufficiently low (less than 90%), point estimates of causal
effect should be interpreted with caution due to regression
dilution, and adjustment methods such as SIMEX should be
considered as part of a sensitivity analysis.
Supplementary Data
Supplementary data are available at IJE online.
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